(Q36228225)

12 August 2017

1 reference

title

Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism? (English)

1 reference

12 August 2017

0 references

Robert M Roth

1

1 reference

12 August 2017

Mary F Brunette

series ordinal

2

1 reference

12 August 2017

Alan I Green

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Current Psychiatry Reports

12 August 2017

published in

1 reference

12 August 2017

volume

7

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

283-291

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-005-0082-8

12 August 2017

exact match

0 references

cites work

Patterns of current and lifetime substance use in schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0082-8

Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0082-8

Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0082-8

The cost of treating substance abuse patients with and without comorbid psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0082-8

Divalproex loading in the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0082-8

A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0082-8

Pharmacological treatment of substance-abusing schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0082-8

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0082-8

Impact of an early psychosis program on substance use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0082-8

Anhedonia, positive and negative affect, and social functioning in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0082-8

Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0082-8

Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0082-8

Marijuana use in schizophrenia: a clear hazard

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0082-8

Preliminary evidence of improved verbal working memory performance and normalization of task-related frontal lobe activation in schizophrenia following cognitive exercises.

21 January 2018

1 reference

12 December 2020

Testing hypotheses about the relationship between cannabis use and psychosis

1 reference

12 December 2020

Functional magnetic resonance imaging of cocaine craving

1 reference

12 December 2020

Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study

1 reference

12 December 2020

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia

1 reference

12 December 2020

Addiction as a computational process gone awry

1 reference

12 December 2020

Alcohol use and abuse in schizophrenia. A prospective community study

1 reference

12 December 2020

Gabapentin reduces cocaine use among addicts from a community clinic sample

1 reference

12 December 2020

Neuroscience. Addiction as compulsive reward prediction.

1 reference

12 December 2020

Schizophrenia: a neural diathesis-stress model

1 reference

12 December 2020

Brain reward circuitry: insights from unsensed incentives

1 reference

12 December 2020

Schizophrenia: diathesis-stress revisited

1 reference

12 December 2020

Neural correlates of behavioral preference for culturally familiar drinks

1 reference

12 December 2020

Moderate drinking among people with severe mental illness

1 reference

12 December 2020

A neurobiological basis for substance abuse comorbidity in schizophrenia

1 reference

12 December 2020

Outcomes of managing disability benefits among patients with substance dependence and severe mental illness

1 reference

12 December 2020

Motivational interviewing among psychiatric in-patients with substance use disorders

1 reference

12 December 2020

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

1 reference

12 December 2020

Olanzapine treatment for patients with schizophrenia and substance abuse

1 reference

12 December 2020

The addicted human brain: insights from imaging studies

1 reference

12 December 2020

Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder

1 reference

12 December 2020

Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia

1 reference

12 December 2020

Beauty in a smile: the role of medial orbitofrontal cortex in facial attractiveness.

1 reference

12 December 2020

Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia

1 reference

12 December 2020

Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia

1 reference

12 December 2020

Alcohol dependence and hospitalization in schizophrenia

1 reference

12 December 2020

The association between high nicotine dependence and severe mental illness may be consistent across countries.

1 reference

12 December 2020

First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol

1 reference

12 December 2020

A review of MRI findings in schizophrenia

1 reference

12 December 2020

Evolving use of buprenorphine in the treatment of addiction

1 reference

12 December 2020

The neural circuitry of reward and its relevance to psychiatric disorders

1 reference

12 December 2020

Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence

1 reference

12 December 2020

Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism

1 reference

12 December 2020

A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI.

1 reference

12 December 2020

Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

1 reference

12 December 2020

The self-medication hypothesis of substance use disorders: a reconsideration and recent applications

1 reference

12 December 2020

Haloperidol increases smoking in patients with schizophrenia

1 reference

12 December 2020

Investigating the use of contingency management in the treatment of cocaine abuse among individuals with schizophrenia: a feasibility study

1 reference

12 December 2020

Examining an affect regulation model of substance abuse in schizophrenia. The role of traits and coping.

1 reference

12 December 2020

Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature

1 reference

12 December 2020

Acute alcohol effects on neuronal and attentional processing: striatal reward system and inhibitory sensory interactions under acute ethanol challenge

1 reference

12 December 2020

Drug-activation of brain reward pathways.

1 reference

12 December 2020

Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden

1 reference

12 December 2020

Heroin and schizophrenia: subjective responses to abused drugs in dually diagnosed patients

1 reference

12 December 2020

A pilot trial of topiramate for the treatment of cocaine dependence

1 reference

12 December 2020

Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity

1 reference

12 December 2020

Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex

1 reference

12 December 2020

Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients.

1 reference

12 December 2020

Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability

1 reference

12 December 2020

alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs

1 reference

12 December 2020

Alcohol promotes dopamine release in the human nucleus accumbens

1 reference

12 December 2020

Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome

1 reference

12 December 2020

Disulfiram treatment for alcoholism in severe mental illness

1 reference

12 December 2020

A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder

1 reference

12 December 2020

An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine

1 reference

12 December 2020

Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study.

1 reference

12 December 2020

Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation.

1 reference

12 December 2020

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

12 December 2020

A comparison of smoking behaviours between patients treated with clozapine and depot neuroleptics

1 reference

12 December 2020

1 reference

12 December 2020

Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia

1 reference

12 December 2020

Relationships between symptoms of schizophrenia and substance abuse

1 reference

12 December 2020

A Review of Treatments for People with Severe Mental Illnesses and Co-Occurring Substance Use Disorders.

1 reference

12 December 2020

Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium

1 reference

12 December 2020

A brief motivational intervention for substance misuse in recent-onset psychosis

1 reference

12 December 2020

Adjunctive imipramine in substance-abusing dysphoric schizophrenic patients

1 reference

12 December 2020

Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes

1 reference

12 December 2020

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study

1 reference

12 December 2020

A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders

1 reference

12 December 2020

Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes

1 reference

12 December 2020

Effects of antipsychotic drugs on operant responding after acute and repeated administration

1 reference

12 December 2020

Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey

1 reference

12 December 2020

Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.

1 reference

12 December 2020

Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence.

1 reference

12 December 2020

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone

1 reference

12 December 2020

Quetiapine in bipolar disorder and cocaine dependence

1 reference

12 December 2020

Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia

1 reference

12 December 2020

Concomitant clozapine reduces smoking in patients treated with risperidone

1 reference

12 December 2020

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

1 reference

12 December 2020

Development of alcohol-associated cues and cue-induced brain activation in alcoholics

1 reference

12 December 2020

Clinical implications of reinforcement as a determinant of substance use disorders

1 reference

12 December 2020

Is Substance Abuse in Schizophrenia Related to Impulsivity, Sensation Seeking, or Anhedonia?

1 reference

12 December 2020

Substance abuse in schizophrenia: a review

1 reference

12 December 2020

Addictive Drugs and Brain Stimulation Reward

1 reference

12 December 2020

Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence

1 reference

12 December 2020

Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity

1 reference

12 December 2020

Persistent cue-evoked activity of accumbens neurons after prolonged abstinence from self-administered cocaine.

1 reference

12 December 2020

Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing.

1 reference

12 December 2020

Relationship between the five-factor model of personality and Axis I disorders in a nonclinical sample

1 reference

12 December 2020

Substance use disorders in schizophrenia: review, integration, and a proposed model

1 reference

12 December 2020

Subjective experiences related to alcohol use among schizophrenics

1 reference

12 December 2020

Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups

1 reference

12 December 2020

Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors.

1 reference

12 December 2020

Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature

1 reference

12 December 2020

Six-month outcomes for patients who switched to olanzapine treatment

1 reference

12 December 2020

Acute marijuana effects on rCBF and cognition: a PET study.

1 reference

12 December 2020

Assessing substance use disorder in persons with severe mental illness

1 reference

12 December 2020

Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment

1 reference

12 December 2020

10.1007/S11920-005-0082-8

Identifiers

DOI

1 reference

release_nuluh5fzxvesrk4m5wgzqxgrmi

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nuluh5fzxvesrk4m5wgzqxgrmi

24 November 2022

mapped directly with Wikidata item

1 reference